Revenue
2022
2023
2024
2025
Lexeo Therapeutics, Inc. (LXEO)
Price$4.89Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $654,000 |
| Research & development | $63.8M | $74.1M | $53.1M | $49.2M |
| Operating expenses | $109.3M | $105.8M | $68.5M | $61.2M |
| Operating income | −$109.3M | −$105.8M | −$68.5M | −$60.5M |
| Operating margin | — | — | — | −9,252.14% |
| EBITDA | −$109.0M | −$105.5M | −$68.2M | −$60.4M |
| EBITDA margin | — | — | — | −9,233.79% |
| Net income | −$100.0M | −$98.3M | −$66.4M | −$59.3M |
| Net profit margin | — | — | — | −9,063.76% |
| Basic EPSper basic share | -$1.86 | -$3.09 | -$12.40 | -$36.36 |
| Diluted EPSper diluted share | -$1.86 | -$3.09 | -$12.40 | -$36.36 |
Owners
Reported shareholders
8.12%of listed shares
MONTANOVA CAPITAL, LLC6.38M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
MONTANOVA CAPITAL, LLC | 8.12%6.38M shares |
Affinity Asset Advisors, LLC | 7.39%5.81M shares |
BlackRock, Inc. | 7.30%5.74M shares |
RA CAPITAL MANAGEMENT, L.P. | 6.36%5M shares |
Frazier Life Sciences Management, L.P. | 6.14%4.82M shares |
STATE STREET CORP | 5.54%4.35M shares |
Vestal Point Capital, LP | 5.49%4.32M shares |
Paradigm Biocapital Advisors LP | 5.31%4.18M shares |
Jupiter Topco LLC | 5.03%3.95M shares |
ORBIMED ADVISORS LLC | 5.02%3.95M shares |
CITADEL ADVISORS LLC | 4.96%3.9M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.98%3.13M shares |
MILLENNIUM MANAGEMENT LLC | 3.60%2.83M shares |
Nantahala Capital Management, LLC | 3.31%2.6M shares |
Woodline Partners LP | 3.18%2.5M shares |
Balyasny Asset Management L.P. | 3.07%2.41M shares |
GOLDMAN SACHS GROUP INC | 2.73%2.15M shares |
683 Capital Management, LLC | 2.38%1.88M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.22%1.75M shares |
ADAR1 Capital Management, LLC | 1.99%1.57M shares |
Percentages use 78.62M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026Form 4 | Otero Jose ManuelChief Operating Officer | SellCommon Stock | 1.3K | $5.07 | $6.6K | 130.1K |
| May 18, 2026Form 4 | Townsend Richard NolanChief Executive Officer | SellCommon Stock | 3.3K | $5.06 | $16.9K | 336.8K |
| Apr 6, 2026Form 4 · 10b5-1 | Townsend Richard NolanChief Executive Officer | SellCommon Stock | 55.0K | $5.69 | $312.9K | 340.1K |
| Feb 18, 2026Form 4 | Otero Jose ManuelChief Operating Officer | SellCommon Stock | 3.0K | $6.40 | $19.3K | 125.5K |
| Feb 18, 2026Form 4 | Townsend Richard NolanChief Executive Officer | SellCommon Stock | 10.2K | $6.38 | $64.9K | 392.5K |